What are the major objectives of the GeneSolve Program?
The major objectives of the GeneSolve program is to support: (a) Challenge driven and (b) Partnership driven, genomics research directly targeted toward solving sector specific technical challenges. The outcome of research must have immediate or near term potential to address the needs of key sectors in BC’s economy and society. GeneSolve aims to:
What kind of projects are eligible for GeneSolve funding?
While the primary focus of GeneSolve is translational research, a full spectrum of projects ranging from discovery to pre-commercialization will be considered under the program. Funding is available for initiatives several socio-economic sectors in BC, including human health, forestry, agri-food, fisheries and aquaculture, mining, energy and environment. Please contact us if you have questions regarding eligibility.
What is the range of funding available for a GeneSolve project?
Sector Partner contributions must match funding provided by Genome BC. Sector Partners can provide more that 1:1 matching if it is in their interest.
What is the cash versus in kind contribution requirement for GeneSolve project?
At least 50% of the approved funding for eligible project costs must be provided by the Sector Partner. Of the first $100,000 of a project budget, the Sector Partner’s contribution must be cash (i.e., $50,000 from Genome BC and $50,000 in cash from the Sector Partner). Thereafter, 50% of the Sector Partner’s contribution mush be cash.
What is the duration of projects funded by GeneSolve?
Projects funded by GeneSolve can be a minimum of 6 months up to a maximum of 24 months.
I am in search of a solution for my company/industry, how do I get my challenge included in GeneSolve?
Contact us. Genome BC works with Sector Partners to understand the challenge and help determine if a genomics based solution is applicable. Then we work with you to establish parameters and agreements to post your challenge to GeneSolve.
When are the intakes for GeneSolve proposals?
GeneSolve has a rolling intake. Submissions deadlines will vary based on the timeline established for each challenge. Proposals will be accepted for active challenges only.
New challenge are added all the time. You can choose to have Genome BC notify you whenever a new challenge is posted when you register for secure access, or by selecting the option in your GeneSolve profile.
Why can I not create a profile on the GeneSolve website?
Genome BC must verify your credentials before you can access GeneSolve.
If you are a researcher looking to respond to a challenge, you must be affiliated with a recognized BC academic institution. Please contact Genome BC if you need assistance.
If you are a potential Sector Partner, and would like to have your challenge added to GeneSolve, please contact Genome BC.
Why should I create a profile on the GeneSolve website?
As an Academic Partner, you must register for access to GeneSolve before you can view complete details of a challenge and submit a proposed solution. You can also choose to receive updates when new challenges are posted.
How is my confidentiality ensured when my company posts a challenge to GeneSolve?
Confidentiality is very important to Genome BC so we will work with Sector Partners to post challenges to GeneSolve. The Sector Partner always has control over the information that is posted.
Sector Partners also have the option to keep their organization anonymous until proposed solutions to their challenge have been shortlisted.
Shortlisted candidates will sign a Nondisclosure Agreement with the Sector Partner before information beyond the posted challenge is discussed.
Only Academic Partners affiliated with a recognized BC post-secondary institution can register to view the details of your challenge.
Who owns any Intellectual Property developed under GeneSolve?
Intellectual Property is negotiated between the BC post-secondary institution and the Sector Partner. Genome BC will not take ownership in any intellectual property generated as a result of a project funded through GeneSolve.